4-demethoxydaunorubicin has sufficient antileukemic activity in both acute lymphocytic leukemia and acute nonlymphocytic leukemia to warrant a prospective comparison , in combination regimens , against the conventional anthracyclines , daunorubicin and/or doxorubicin .
C0020789
4-demethoxydaunorubicin
C0023467
acute nonlymphocytic leukemia